Disease State
Understanding Through
Biogen Educational Events

Your resource for videos and highlights from Biogen sponsored symposia and educational events

The Early Diagnosis of Alzheimer’s: Readying the Health System
The Early Diagnosis of Alzheimer’s: Readying the Health System

Alzheimer’s Disease

July 27–31, 2020

The Early Diagnosis of Alzheimer’s: Readying the Health System

At the Alzheimer’s Association International Conference 2020, an expert panel outlined the importance of an early diagnosis of Alzheimer’s disease, including the role of clinical assessment tools and biomarkers, alongside the effect of the Covid-19 pandemic.

Abstract watercolor image

Alzheimer’s Disease

May 24, 2020

The Early Diagnosis of Alzheimer’s: Delineating the Cause of Memory Impairment

At the virtual 6th Congress of the European Academy of Neurology 2020, an expert panel outlined the importance of an early diagnosis of Alzheimer’s disease (AD) and healthcare system readiness.

Alzheimer’s Disease

March 29, 2019

The Early Diagnosis of Alzheimer’s: Exploring Pathological Obstacles

At the International Conference on Alzheimer’s and Parkinson’s Disease 2019, an expert panel discussed the clinical presentation of Alzheimer’s disease (AD) in the early stages and outlined the role of cognitive assessment tools and biomarkers in supporting the early diagnosis.

Abstract watercolor image

Alzheimer’s Disease

July 23, 2018

The Early Diagnosis of Alzheimer’s: Exploring a Patient with Memory Complaints and Identifying Underlying Pathologies

At the Alzheimer’s Association International Conference 2018, an expert panel discussed the importance of an early diagnosis of Alzheimer’s disease (AD).

STROKE

February 6, 2019

Understanding Severe Stroke Recognition & Management

At the 2019 International Stroke Conference, Biogen collaborated with a panel of experts to outline and discuss key considerations for the recognition and treatment of large hemispheric infarction (LHI).

psp
psp

PSP

September 23, 2019

Differentiating PSP

At the 2019 International Congress of Parkinson’s Disease and Movement Disorders, an expert panel discussed the early clinical presentation of progressive supranuclear palsy (PSP), the differentiation of PSP from Parkinson’s disease, and the burden of disease.